These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32578132)

  • 1. Mepolizumab Therapy for Recalcitrant Eosinophilic Annular Erythema in an Adult: A Case Report and Review of Treatment Options.
    Żychowska M; Tutka K; Reich A
    Dermatol Ther (Heidelb); 2020 Aug; 10(4):893-899. PubMed ID: 32578132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone for Recalcitrant Eosinophilic Annular Erythema: A Case Report and Literature Review.
    Wallis L; Gilson RC; Gilson RT
    Dermatol Ther (Heidelb); 2018 Mar; 8(1):157-163. PubMed ID: 29222624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Eosinophilic Annular Erythema: Retrospective multicenter study and literature review.
    Chastagner M; Shourik J; Jachiet M; Battistella M; Lefevre G; Gibier JB; Aubert H; Musquer M; Descamps V; Deschamps L; Chosidow O; Ortonne N; Groh M; Bernier M; Jullien D; Chasset F; Staumont-Salle D; Bouaziz JD; Kanitakis J; Villani AP
    Ann Dermatol Venereol; 2022 Jun; 149(2):123-127. PubMed ID: 34716028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic Annular Erythema Responding to Doxycycline.
    Young JN; Chung J; Fett N
    Cureus; 2023 Oct; 15(10):e47478. PubMed ID: 38022231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine.
    Ljubojević Hadžavdić S; Bartolić L; Bradamante M
    Acta Dermatovenerol Croat; 2018 Oct; 26(3):262-263. PubMed ID: 30390730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic Annular Erythema: A New Entity of Eosinophilic Dermatosis.
    Eljazouly M; Chahboun F; Alj M; Oqbani K; Chiheb S
    Cureus; 2022 Feb; 14(2):e22657. PubMed ID: 35371819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eosinophilic-like erythema: a clinical subset of Wells' eosinophilic cellulitis responding to antimalarial drugs?].
    Dereure O; Guilhou JJ
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 1):720-3. PubMed ID: 12124515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic annular erythema: successful response to ultraviolet B therapy.
    Thomas L; Fatah S; Nagarajan S; Natarajan S
    Clin Exp Dermatol; 2015 Dec; 40(8):883-6. PubMed ID: 25958878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IL5 therapies for asthma.
    Farne HA; Wilson A; Powell C; Bax L; Milan SJ
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD010834. PubMed ID: 28933516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic annular erythema is a peculiar subtype in the spectrum of Wells syndrome: a multicentre long-term follow-up study.
    El-Khalawany M; Al-Mutairi N; Sultan M; Shaaban D
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):973-9. PubMed ID: 22731886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic annular erythema: A late but complete response to hydroxychloroquine.
    Karataş Toğral A; Seçkin D
    Australas J Dermatol; 2017 Aug; 58(3):228-230. PubMed ID: 26768795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic annular erythema is clinically characterized by central pigmentation reflecting basal melanosis: a clinicopathological study of 10 cases.
    Nakazato S; Fujita Y; Shinkuma S; Nomura T; Shimizu H
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1916-1923. PubMed ID: 28543605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IL-5 therapies for asthma.
    Farne HA; Wilson A; Milan S; Banchoff E; Yang F; Powell CV
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD010834. PubMed ID: 35838542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
    Drugs R D; 2008; 9(2):125-30. PubMed ID: 18298130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic annular erythema.
    Dacy N; Oney K; Fiala K; Parekh P
    Proc (Bayl Univ Med Cent); 2021 Sep; 34(5):606-607. PubMed ID: 34456486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of eosinophilic cellulitis (Wells syndrome) - a systematic review.
    Räßler F; Lukács J; Elsner P
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1465-79. PubMed ID: 27357601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Annular erythema in childhood--a new eosinophilic dermatosis].
    Kunz M; Hamm K; Bröcker EB; Hamm H
    Hautarzt; 1998 Feb; 49(2):131-4. PubMed ID: 9551336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic annular erythema in adults: report of two cases and review of the literature.
    Heras MO; Muñoz NP; Sancho MI; Millet PU
    An Bras Dermatol; 2017; 92(5 Suppl 1):65-68. PubMed ID: 29267450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial.
    Chupp GL; Bradford ES; Albers FC; Bratton DJ; Wang-Jairaj J; Nelsen LM; Trevor JL; Magnan A; Ten Brinke A
    Lancet Respir Med; 2017 May; 5(5):390-400. PubMed ID: 28395936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.